Found 3077 matching trials
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
PHASE2Despite the impressive response rate to PD-1/PD-L1 immune checkpoint inhibi...
Location
Fudan University Shanghai Cancer Center
COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)
N/APatients with loco-regional NSCLC planned for curative treatment with chemo...
Location
Odense University Hospital
Personalized Cancer Therapy for Patients With Metastatic Medullary Thyroid or Metastatic Colon Cancer
NAThe Personalized Discovery Process is the only program offering patients tr...
Location
Icahn School of Medicine at Mount Sinai
Dovitinib for Gastric Cancer With FGFR2 Amplification: GASDOVI-1
PHASE2This is a single-center, prospective, single-arm, open-label phase II study...
Location
Asan Medical Center
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma
PHASE2The study is being conducted to evaluate the efficacy and safety of convers...
Location
Shandong Cancer Hospital and Institute
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease
PHASE4Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Location
Cleveland Clinic Main Campus
A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous Treatment
PHASE3To compare, in zidovudine (AZT)-naive patients, the safety, tolerance, and ...
Location
Phoenix Body Positive
Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases
PHASE2This is a single arm, multicenter phase II trial for 60 patients with untre...
Usefulness and Safeness Of Intra-Gastric Balloon Before Bariatric Surgery In Morbid Obesity
NAIntroduction: bariatric surgery shows an important morbidity and there are ...
Location
Gastroenterology Department ,Severo Ochoa Hospital
Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal Cancer
N/AA growing amount of reports has consistently evidenced that a sustained inh...
Location
Azienda Ospedaliero Universitaria Pisana